Intracranial Angioplasty with Enterprise Stent for Intracranial Atherosclerotic Stenosis: A Single-Center Experience and a Systematic Review

Table 3

Summary of adverse events after Enterprise implantation.

Study	Intraprocedural complications	Any stroke or death within 30 days				Ischemic stroke or TIA in the territory of the qualifying artery beyond 30 days	Mortality beyond 30 days	ISR
		Stoke		Nonfatal stroke	Death			Asymptomatic	Symptomatic
		Hemorrhagic	Ischemic
Vajda 2012	4/209	8/189	10/189	16/189	2/189	4	0/174	39/174	4/44
Feng 2015	0/44	1/44	3/44	4/44	0/44	0	0/44	1/44	2/44
Lee 2016	0/30	1/24	2/24	2/24	1/24	0	0/24	1/20	0/20
Wang 2016	3/62	0/60	2/60	2/60	0/60	5	0/60	1/45	5/45
Huang 2019	0/70	2/68	1/68	3/68	0/68	NA	NA	NA	NA
Salik 2019	1/68	0/68	0/68	1/68	0/68	0	0/68	2/60	0/60
Present	0/105	3/104	4/104	6/104	1/104	NA	NA	NA	NA

NA: not available.